Medicare Will Cover Dexcom G5 CGM

By GabbyPA Latest Reply 2017-04-11 15:01:34 -0500
Started 2017-04-11 07:05:09 -0500

Exciting news long awaited by so many! Not everyone will qualify, but it's at least a start for those who depend on insulin to keep them alive.

"On March 24, Medicare announced that it will now reimburse “therapeutic continuous glucose monitoring” (CGM) devices for people with type 1 or type 2 diabetes on intensive insulin therapy (“MDI” – multiple daily injections – or a pump). This milestone is a big deal because it establishes reimbursement for Dexcom’s G5 CGM, the only “therapeutic CGM” – meaning it has FDA approval for making diabetes decisions without a confirmatory finger stick – currently available in the US."

Here is the full article:

4 replies

Luis65 2017-04-11 14:44:26 -0500 Report

I doubt I would meet the requirements, but this is good news.

WASHED OUT 2017-04-11 15:01:34 -0500 Report

The requirements may still be very strict to where we have to test low on body produced insulin. I think they should open up those requirements to higher numbers that would include more patients without having to have your doctor appeal the coverage denial. Some insurers require a C-peptide test result below .5 nanograms/ml before they will cover the costs of an insulin pump.

WASHED OUT 2017-04-11 14:02:26 -0500 Report

If this is so then it is great. People who need this the most can get the life saving help they need.

GabbyPA 2017-04-11 14:25:36 -0500 Report

I certainly hope so. It's on reimbursement (not great) but at least they are starting to cover the tools some of us really need.